Bahamas vs Mauritania: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bahamas
85.0%
in 2025
Mauritania
85.0%
in 2025
Bahamas rank
96th
Mauritania rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bahamas
- Mauritania
How they compare
Bahamas currently reports 85.0% against 85.0% in Mauritania, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Mauritania ahead.
Bahamas ranks 96th and Mauritania ranks 96th of 194 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Bahamas | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 0.0% | 1.5% | Bahamas |
| 2010s | 69.3% | 43.4% | 25.9% | Bahamas |
| 2020s | 83.0% | 84.0% | 1.0% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bahamas or Mauritania?
- Bahamas, at 85.0% against 85.0% in Mauritania as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bahamas and Mauritania?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Mauritania?
- 18 years are reported by both, from 2008 to 2025.
- How do Bahamas and Mauritania rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bahamas ranks 96th and Mauritania ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.